195 related articles for article (PubMed ID: 20107107)
1. The natural protective mechanism against hyperglycemia in vascular endothelial cells: roles of the lipid peroxidation product 4-hydroxydodecadienal and peroxisome proliferator-activated receptor delta.
Riahi Y; Sin-Malia Y; Cohen G; Alpert E; Gruzman A; Eckel J; Staels B; Guichardant M; Sasson S
Diabetes; 2010 Apr; 59(4):808-18. PubMed ID: 20107107
[TBL] [Abstract][Full Text] [Related]
2. PPARδ agonist prevents endothelial dysfunction via induction of dihydrofolate reductase gene and activation of tetrahydrobiopterin salvage pathway.
Zhang Z; Xie X; Yao Q; Liu J; Tian Y; Yang C; Xiao L; Wang N
Br J Pharmacol; 2019 Aug; 176(16):2945-2961. PubMed ID: 31144304
[TBL] [Abstract][Full Text] [Related]
3. Role of lipid peroxidation and PPAR-δ in amplifying glucose-stimulated insulin secretion.
Cohen G; Riahi Y; Shamni O; Guichardant M; Chatgilialoglu C; Ferreri C; Kaiser N; Sasson S
Diabetes; 2011 Nov; 60(11):2830-42. PubMed ID: 21896929
[TBL] [Abstract][Full Text] [Related]
4. Development of a novel monoclonal antibody against 4-hydroxy-2E,6Z-dodecadienal (4-HDDE)-protein adducts: Immunochemical application in quantitative and qualitative analyses of lipid peroxidation in vitro and ex vivo.
Uchida K; Shibata T; Toyokuni S; Daniel B; Zarkovic K; Zarkovic N; Sasson S
Free Radic Biol Med; 2018 Aug; 124():12-20. PubMed ID: 29807161
[TBL] [Abstract][Full Text] [Related]
5. 4-Hydroxyalkenal-activated PPARδ mediates hormetic interactions in diabetes.
Sasson S
Biochimie; 2017 May; 136():85-89. PubMed ID: 27768859
[TBL] [Abstract][Full Text] [Related]
6. The PPARδ-mediated inhibition of angiotensin II-induced premature senescence in human endothelial cells is SIRT1-dependent.
Kim MY; Kang ES; Ham SA; Hwang JS; Yoo TS; Lee H; Paek KS; Park C; Lee HT; Kim JH; Han CW; Seo HG
Biochem Pharmacol; 2012 Dec; 84(12):1627-34. PubMed ID: 23000914
[TBL] [Abstract][Full Text] [Related]
7. Ligand-Activated Peroxisome Proliferator-Activated Receptor δ Attenuates Vascular Oxidative Stress by Inhibiting Thrombospondin-1 Expression.
Ahn MY; Ham SA; Yoo T; Lee WJ; Hwang JS; Paek KS; Lim DS; Han SG; Lee CH; Seo HG
J Vasc Res; 2018; 55(2):75-86. PubMed ID: 29408825
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor-delta upregulates 14-3-3 epsilon in human endothelial cells via CCAAT/enhancer binding protein-beta.
Brunelli L; Cieslik KA; Alcorn JL; Vatta M; Baldini A
Circ Res; 2007 Mar; 100(5):e59-71. PubMed ID: 17303761
[TBL] [Abstract][Full Text] [Related]
9. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
Coll T; Alvarez-Guardia D; Barroso E; Gómez-Foix AM; Palomer X; Laguna JC; Vázquez-Carrera M
Endocrinology; 2010 Apr; 151(4):1560-9. PubMed ID: 20185762
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol ameliorates endothelial dysfunction in diabetic and obese mice through sirtuin 1 and peroxisome proliferator-activated receptor δ.
Cheang WS; Wong WT; Wang L; Cheng CK; Lau CW; Ma RCW; Xu A; Wang N; Huang Y; Tian XY
Pharmacol Res; 2019 Jan; 139():384-394. PubMed ID: 30503839
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor δ rescues xCT-deficient cells from ferroptosis by targeting peroxisomes.
Hwang JS; Kim E; Lee HG; Lee WJ; Won JP; Hur J; Fujii J; Seo HG
Biomed Pharmacother; 2021 Nov; 143():112223. PubMed ID: 34649350
[TBL] [Abstract][Full Text] [Related]
12. Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta.
Krämer DK; Al-Khalili L; Perrini S; Skogsberg J; Wretenberg P; Kannisto K; Wallberg-Henriksson H; Ehrenborg E; Zierath JR; Krook A
Diabetes; 2005 Apr; 54(4):1157-63. PubMed ID: 15793256
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta1 is a molecular target for the peroxisome proliferator-activated receptor delta.
Kim HJ; Ham SA; Kim SU; Hwang JY; Kim JH; Chang KC; Yabe-Nishimura C; Kim JH; Seo HG
Circ Res; 2008 Feb; 102(2):193-200. PubMed ID: 18007025
[TBL] [Abstract][Full Text] [Related]
14. Calreticulin destabilizes glucose transporter-1 mRNA in vascular endothelial and smooth muscle cells under high-glucose conditions.
Totary-Jain H; Naveh-Many T; Riahi Y; Kaiser N; Eckel J; Sasson S
Circ Res; 2005 Nov; 97(10):1001-8. PubMed ID: 16210549
[TBL] [Abstract][Full Text] [Related]
15. Ligand-activated PPARδ upregulates α-smooth muscle actin expression in human dermal fibroblasts: A potential role for PPARδ in wound healing.
Ham SA; Hwang JS; Yoo T; Lee WJ; Paek KS; Oh JW; Park CK; Kim JH; Do JT; Kim JH; Seo HG
J Dermatol Sci; 2015 Dec; 80(3):186-95. PubMed ID: 26481780
[TBL] [Abstract][Full Text] [Related]
16. Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle.
Krämer DK; Al-Khalili L; Guigas B; Leng Y; Garcia-Roves PM; Krook A
J Biol Chem; 2007 Jul; 282(27):19313-20. PubMed ID: 17500064
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor δ improves porcine blastocyst hatching via the regulation of fatty acid oxidation.
Guo J; Lu WF; Liang S; Choi JW; Kim NH; Cui XS
Theriogenology; 2017 Mar; 90():266-275. PubMed ID: 28166979
[TBL] [Abstract][Full Text] [Related]
18. Metformin inhibits PPARδ agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cells.
Ding J; Gou Q; Jin J; Shi J; Liu Q; Hou Y
Eur J Pharmacol; 2019 Aug; 857():172425. PubMed ID: 31150647
[TBL] [Abstract][Full Text] [Related]
19. Procyanidin B2 mitigates endothelial endoplasmic reticulum stress through a PPARδ-Dependent mechanism.
Nie X; Tang W; Zhang Z; Yang C; Qian L; Xie X; Qiang E; Zhao J; Zhao W; Xiao L; Wang N
Redox Biol; 2020 Oct; 37():101728. PubMed ID: 32961442
[TBL] [Abstract][Full Text] [Related]
20. Paeonol protects against endoplasmic reticulum stress-induced endothelial dysfunction via AMPK/PPARδ signaling pathway.
Choy KW; Mustafa MR; Lau YS; Liu J; Murugan D; Lau CW; Wang L; Zhao L; Huang Y
Biochem Pharmacol; 2016 Sep; 116():51-62. PubMed ID: 27449753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
